StockNow
CalendarLog in
U.S. Markets

Moderna (MRNA) affirms their 2028 break-even and up to 10% 2026 top-line growth

StockNow breaking-news AI analysis

Moderna reaffirmed its 2028 break-even target and up to 10% 2026 top-line growth, maintaining its framework without raising expectations despite strong 5-product vaccine enthusiasm.

News detail

Retains its existing growth model as the appropriate framework. Resists raising expectations despite strong enthusiasm for the 5-product vaccine portfolio.

1 stocks
MRNAModerna, Inc. Common Stock$145.83Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

US President Trump says "The only control or “guardrails” that AI needs is a STRONG AND SMART (High IQ!) PRESIDENT, and the U.S.A. has that,"

Commodities

A crucial Saudi oil pipeline hit in strikes will be mostly out of service for several weeks for repairs, reports AP citing officials

Geopolitics

US President Trump says Ukraine has agreed not to hit Russian Energy targets. Russia has agreed to do, likewise!